These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38378236)

  • 1. Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?
    van der Woude D; Toes REM
    Ann Rheum Dis; 2024 Jun; 83(7):838-846. PubMed ID: 38378236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
    Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
    Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
    Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.
    Slot LM; Vergroesen RD; Kerkman PF; Staudinger E; Reijm S; van Dooren HJ; van der Voort EIH; Huizinga TWJ; Toes REM; Scherer HU
    PLoS One; 2021; 16(3):e0247847. PubMed ID: 33784344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
    Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and anti-citrullinated protein antibodies: Building blocks in RA.
    van der Woude D; Catrina AI
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):692-705. PubMed ID: 27107507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
    Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
    Front Immunol; 2021; 12():627986. PubMed ID: 34093522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
    Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
    Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies and the autoreactive immune response : There is more to ACPA than ACPA].
    Scherer HU
    Z Rheumatol; 2020 Nov; 79(9):893-897. PubMed ID: 32970187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
    Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
    Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.
    Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M
    Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Vergroesen RD; Slot LM; van Schaik BDC; Koning MT; Rispens T; van Kampen AHC; Toes REM; Scherer HU
    Front Immunol; 2019; 10():2092. PubMed ID: 31572358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications.
    Kissel T; Reijm S; Slot LM; Cavallari M; Wortel CM; Vergroesen RD; Stoeken-Rijsbergen G; Kwekkeboom JC; Kampstra A; Levarht E; Drijfhout JW; Bang H; Bonger KM; Janssen G; van Veelen PA; Huizinga T; Scherer HU; Reth M; Toes R
    Ann Rheum Dis; 2020 Apr; 79(4):472-480. PubMed ID: 32041746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of ACPA status and characteristics on the course of RA.
    Willemze A; Trouw LA; Toes RE; Huizinga TW
    Nat Rev Rheumatol; 2012 Jan; 8(3):144-52. PubMed ID: 22293763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role for mast cells and basophils?
    Suurmond J; Schuerwegh AJ; Toes RE
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i55-8. PubMed ID: 21339220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification.
    Kampstra ASB; Dekkers JS; Volkov M; Dorjée AL; Hafkenscheid L; Kempers AC; van Delft M; Kissel T; Reijm S; Janssen GMC; van Veelen PA; Bang H; Huizinga TWJ; Trouw LA; van der Woude D; Toes REM
    Ann Rheum Dis; 2019 Jul; 78(7):908-916. PubMed ID: 31151934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on autoantibodies to modified proteins.
    Toes RE; Huizinga TJ
    Curr Opin Rheumatol; 2015 May; 27(3):262-7. PubMed ID: 25760280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
    Kongpachith S; Lingampalli N; Ju CH; Blum LK; Lu DR; Elliott SE; Mao R; Robinson WH
    Arthritis Rheumatol; 2019 Apr; 71(4):507-517. PubMed ID: 30811898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.